Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection

被引:15
|
作者
Thakral, Charu [1 ]
Abraham, Jerrold L. [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
关键词
Nephrogenic systemic fibrosis; Histopathology; Gadolinium; Scanning electron microscopy; Energy dispersive x-ray spectroscopy; Mass spectrometry; Tissue analysis; Secondary ion mass spectrometry; LONG-TERM RETENTION; STAGE RENAL-DISEASE; CONTRAST AGENTS; DERMOPATHY; TISSUE; SKIN; QUANTIFICATION; INVOLVEMENT; MICROSCOPY; DEPOSITION;
D O I
10.1016/j.rcl.2009.06.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The association between gadolinium (Gd)-containing MR imaging contrast agents and the development of nephrogenic systemic fibrosis (INISF) is well recognized. The authors review the histopathologic features, methodology, and results Of analysis of tissues for Gd in NSF. Scanning electron microscopy/energy dispersive xray spectroscopy (SEM/EDS) provides sensitive detection of individual Gd-containing deposits in situ. Secondary ion mass spectroscopy has far greater sensitivity for detection of Gd than SEM/EDS and allows correlation at the cellular level. Inductively coupled plasma mass spectrometry is the recognized method for full quantitative analysis of Gd in tissues but requires destruction of the tissue and does not allow spatial correlation. In practice, the different analytic techniques provide complementary data and can be selected based on the information required.
引用
收藏
页码:841 / +
页数:15
相关论文
共 50 条
  • [41] Free Gadolinium Is a Likely Trigger of Nephrogenic Systemic Fibrosis Reply
    Kuo, Phillip H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (04) : W355 - W355
  • [42] Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update
    Idee, Jean-Marc
    Port, Marc
    Dencausse, Anne
    Lancelot, Eric
    Corot, Claire
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2009, 47 (05) : 855 - +
  • [43] Nephrogenic systemic fibrosis after gadolinium exposure:: 5 cases
    Burkhalter, F.
    Fischer, A.
    Sandoz, P.
    Schoenholzer, C.
    Haeuser-Mann, P.
    Mayr, M.
    SWISS MEDICAL WEEKLY, 2007, 137 : S17 - S17
  • [44] Nephrogenic systemic fibrosis and gadolinium-based contrast media
    Andrejak, Michel
    Thuillier, Delphine
    Lok, Catherine
    Gras-Champel, Valerie
    THERAPIE, 2007, 62 (02): : 169 - 172
  • [45] Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis
    High, Whitney A.
    Ayers, Reed A.
    Cowper, Shawn E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 710 - 712
  • [46] Ocular Pathologic Features and Gadolinium Deposition in Nephrogenic Systemic Fibrosis
    Barker-Griffith, Ann
    Goldberg, Jacqueline
    Abraham, Jerrold L.
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (05) : 661 - 663
  • [47] NEPHROGENIC SYSTEMIC FIBROSIS: A GADOLINIUM-INDUCED FIBROSING DISORDER
    Kay, Jonathan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S79 - S79
  • [48] Gadolinium-based Contrast Agents and Nephrogenic Systemic Fibrosis
    Vitti, Richard A.
    RADIOLOGY, 2009, 250 (03) : 959 - 959
  • [50] Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure
    Bernstein, Elana J.
    Schmidt-Lauber, Christian
    Kay, Jonathan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (04): : 489 - 503